Am J Epidemiol 2003; 158:629-638.
Copyright © 2003 by Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Reproductive Factors and Epithelial Ovarian Cancer Risk by Histologic Type:A Multiethnic Case-Control Study
1 Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI.
2 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.
3 Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI.
4 World Health Organization Collaborating Center for International Histological Classification of Tumors, Armed Forces Institute of Pathology, Washington, DC.
Associations of reproductive factors with ovarian cancer may differ by histologic type. Data from a multiethnic, population-based, case-control study, conducted in Hawaii and Los Angeles, California, between 1993 and 1999, were used to assess this hypothesis. A structured questionnaire was administered to 558 histologically confirmed epithelial ovarian cancer cases and 607 population controls. Factors suppressing ovulation, including pregnancy and oral contraceptive use, were inversely associated with the risk of all histologic types. Nonmucinous but not mucinous tumors were significantly associated with menstruation years (odds ratio = 1.5 for the highest vs. the lowest quartile) and lifetime ovulatory cycles (odds ratio = 2.8 for the highest vs. the lowest quartile). Duration of breastfeeding (odds ratio = 0.4 for the highest vs. the lowest quartile) was significantly and inversely related to nonmucinous tumors but not to mucinous tumors. Among all tumor types, endometrioid tumors were the most strongly related to pregnancy and tubal ligation, while clear cell tumors were the only type that was associated with noncontraceptive hormone use. The risk factors were similar for borderline and invasive tumors, except for age at diagnosis. Mucinous tumors, both borderline and invasive, were more common in Asian women than in Caucasian and other women. Our data suggest that histologic types of epithelial ovarian cancer are etiologically distinct.
breast feeding; case-control studies; contraceptives, oral; histology; ovarian neoplasms; ovulation; parity; pregnancy
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. A. Gates, B. A. Rosner, J. L. Hecht, and S. S. Tworoger Risk Factors for Epithelial Ovarian Cancer by Histologic Subtype Am. J. Epidemiol., January 1, 2010; 171(1): 45 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. L. Romero, I. O. Gordon, S. Jagadeeswaran, K. L. Mui, W. S. Lee, D. M. Dinulescu, T. N. Krausz, H. H. Kim, M. L. Gilliam, and E. Lengyel Effects of Oral Contraceptives or a Gonadotropin-Releasing Hormone Agonist on Ovarian Carcinogenesis in Genetically Engineered Mice Cancer Prevention Research, September 1, 2009; 2(9): 792 - 799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Robbins, M. K. Whiteman, S. D. Hillis, K. M. Curtis, J. A. McDonald, P. A. Wingo, A. Kulkarni, and P. A. Marchbanks Influence of Reproductive Factors on Mortality after Epithelial Ovarian Cancer Diagnosis Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 2035 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Pal, J. Permuth-Wey, A. Kumar, and T. A. Sellers Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology Clin. Cancer Res., November 1, 2008; 14(21): 6847 - 6854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chung, G. Raman, T. Trikalinos, J. Lau, and S. Ip Interventions in Primary Care to Promote Breastfeeding: An Evidence Review for the U.S. Preventive Services Task Force Ann Intern Med, October 21, 2008; 149(8): 565 - 582. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lurie, L. R. Wilkens, P. J. Thompson, K. E. McDuffie, M. E. Carney, K. Y. Terada, and M. T. Goodman Genetic Polymorphisms in the Paraoxonase 1 Gene and Risk of Ovarian Epithelial Carcinoma Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2070 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lurie, L. R. Wilkens, P. J. Thompson, K. E. McDuffie, M. E. Carney, K. Y. Terada, and M. T. Goodman Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2566 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Baik, M. Lambe, Q. Liu, S. Cnattingius, L. A. Mucci, T. Riman, A. Ekbom, H.-O. Adami, and C.-C. Hsieh Gender of Offspring and Maternal Risk of Invasive Epithelial Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2314 - 2320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Tworoger, K. M. Fairfield, G. A. Colditz, B. A. Rosner, and S. E. Hankinson Association of Oral Contraceptive Use, Other Contraceptive Methods, and Infertility with Ovarian Cancer Risk Am. J. Epidemiol., October 15, 2007; 166(8): 894 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Greiser, E. M. Greiser, and M. Doren Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis Hum. Reprod. Update, September 1, 2007; 13(5): 453 - 463. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Barua, J. S. Abramowicz, J. M. Bahr, P. Bitterman, A. Dirks, K. A. Holub, E. Sheiner, M. J. Bradaric, S. L. Edassery, and J. L. Luborsky Detection of Ovarian Tumors in Chicken by Sonography: A Step Toward Early Diagnosis in Humans? J. Ultrasound Med., July 1, 2007; 26(7): 909 - 919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Soegaard, A. Jensen, E. Hogdall, L. Christensen, C. Hogdall, J. Blaakaer, and S. K. Kjaer Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1160 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.Q. Yang, K.Y.K. Chan, H.Y.S. Ngan, U.S. Khoo, P.M. Chiu, Q.K.Y. Chan, W.C. Xue, and A.N.Y. Cheung Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility Carcinogenesis, July 1, 2006; 27(7): 1502 - 1506. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The ESHRE Capri Workshop Group Noncontraceptive health benefits of combined oral contraception Hum. Reprod. Update, September 1, 2005; 11(5): 513 - 525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Jordan, P. M. Webb, and A. C. Green Height, Age at Menarche, and Risk of Epithelial Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 2045 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Tung, L. R. Wilkens, A. H. Wu, K. McDuffie, J. H. Hankin, A. M.Y. Nomura, L. N. Kolonel, and M. T. Goodman Association of Dietary Vitamin A, Carotenoids, and Other Antioxidants with the Risk of Ovarian Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 669 - 676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. E. Promislow, B. C. Gladen, and D. P. Sandler Maternal Recall of Breastfeeding Duration by Elderly Women Am. J. Epidemiol., February 1, 2005; 161(3): 289 - 296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lukanova and R. Kaaks Endogenous Hormones and Ovarian Cancer: Epidemiology and Current Hypotheses Cancer Epidemiol. Biomarkers Prev., January 1, 2005; 14(1): 98 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Recent References J Hum Lact, February 1, 2004; 20(1): 106 - 112. [PDF]
|
|